Why the Little Green Pharma (ASX:LGP) share price is on the rise

The Little Green Pharma (ASX:LGP) share price is on the move today after the company announced a large purchase order and expansion plans.

| More on:
asx cannabis shares represented by pug dog pointing to blackboard with cannabis info on it

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Little Green Pharma (ASX: LGP) shares are on the move today after the company announced it has received a large purchase order and has plans for expansion. At the time of writing, the Little Green Pharma share price is trading at 73 cents, up 4.29% from Friday's close. 

Let's take a look at what the medicinal cannabis company reported.

Expansion Plans

The Little Green Pharma share price is heating up after the company announced plans to expand its cultivation and manufacturing facilities in the south west of Western Australia. Little Green Pharma stated it has entered into agreements to purchase both properties underlying its current facilities and two properties adjacent.

Little Green Pharma plans to use the land to double the site's current indoor cultivation capacity and, eventually, quadruple its production. Construction on the expansion is expected to start in the second half of 2021.

Additionally, by purchasing the land the company currently leases, it will avoid paying rental fees of $170,000 per year.

Little Green Pharma estimates the land will cost between $5.5 million and $7.5 million. The funds to purchase the land will be made up of 70% cash and 30% scrip.

A scrip is, in this case, a promise of shares in exchange for goods. It will be valued at the 5-day volume-weighted average price, which the company states is 66.3 cents.

These shares will be new and fully paid and issued with shareholders approval. Though, the company hasn't yet sought shareholder approval. Little Green Pharma stated that if it is unable to obtain shareholder approval, the purchase will either be made entirely in cash or cancelled.

Purchase order from Demecan

The second piece of news driving the Little Green Pharma share price today is the company's announcement regarding a large purchase order from German medical cannabis producer Demecan.

Demecan has placed an order for 9000 x 15g units of the company's cannabis flower medicines.

Little Green Pharma has a standing purchase agreement with Demecan, under which Demecan will purchase up to 1,000kgs of cultivated dried cannabis flower from the company per year.  

The latest purchase order is the second made between the two companies this year, with Demecan having ordered 500 x 15g units in February.

Little Green Pharma share price snapshot

Over the past 12 months, the Little Green Pharma share price has risen by more than 180%. The company's shares are also up by more than 30% year to date.

Based on the current Little Green Pharma share price, the company has a market capitalisation of around $85 million with approximately 176 shares outstanding.

Motley Fool contributor Brooke Cooper has no position in any of the shares mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

The silhouettes of ten people holding hands with their arms raised against the sky, as the sun rises or sets in the background.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors were nervous this Friday, ending the week on a sour note.

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Share Market News

Where to invest $5,000 into ASX 200 shares this month

The team at Bell Potter is bullish on these names. But why?

Read more »

Man pointing an upward line on a bar graph symbolising a rising share price.
52-Week Highs

8 ASX 200 shares hitting multi-year highs today

These shares have defied the trend, hitting new price milestones amid a day in the red for the ASX 200.

Read more »

Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man punches the air in delight as he reacts to great news on his mobile phone.
Share Gainers

Why EOS, Evolution Mining, Renascor, and Woodside shares are jumping today

These shares are ending the week on a high. But why?

Read more »

Person with thumbs down and a red sad face poster covering the face.
Share Fallers

Why Accent, Cettire, Ioneer, and Pro Medicus shares are dropping today

These shares are ending the week in the red. What's going on?

Read more »

A group of three miners in hard hats and high visibility vests confer at a rocky mining site.
Broker Notes

Up 66% in a year, just how much more upside does Macquarie tip for Perseus Mining shares?

Just how much higher might Perseus Mining shares soar? Here’s what Macquarie had to say about the ASX 200 gold…

Read more »

Rising share price chart.
Broker Notes

Why this exciting ASX 200 share could rise almost 50%

Bell Potter has good things to say about this biopharmaceutical company.

Read more »